Sanofi ADR/ US80105N1054 /
| 2024-11-12 9:59:58 PM | Chg. -0.47 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 50.15USD | -0.93% | 129,823 Turnover: 6.52 mill. |
-Bid Size: - | -Ask Size: - | 126.08 bill.USD | - | - |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 9,717 | 9,365 | 10,028 | 9,869 | 10,160 | ||||||
| Intangible Assets | 16,572 | 18,421 | 21,407 | 21,640 | 73,573 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Fixed Assets | 83,800 | 80,743 | 89,589 | 92,611 | 95,644 | ||||||
| Inventories | 7,994 | 8,352 | 8,715 | 8,960 | - | ||||||
| Accounts Receivable | 7,937 | 7,491 | 7,568 | 8,424 | 21,554 | ||||||
| Cash and Cash Equivalents | 9,427 | 13,915 | 10,098 | 12,736 | 8,710 | ||||||
| Current Assets | 28,611 | 33,703 | 30,564 | 34,026 | 30,655 | ||||||
| Total Assets | 112,736 | 114,529 | 120,242 | 126,722 | 126,314 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5,313 | 5,295 | 6,180 | 6,813 | 20,882 | ||||||
| Long-term debt | - | - | - | 16,761 | 14,347 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 2,294 | 1,770 | 1,617 | 20,203 | 7,639 | ||||||
| Liabilities | 53,628 | 51,382 | 51,211 | 51,560 | 51,948 | ||||||
| Share Capital | 2,508 | 2,518 | 2,527 | - | - | ||||||
| Total Equity | 58,934 | 63,001 | 68,681 | 74,784 | 74,040 | ||||||
| Minority Interests | 174 | 146 | 350 | 368 | 313 | ||||||
| Total liabilities equity | 112,736 | 114,529 | 120,242 | 126,722 | 126,314 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 36,126 | 36,041 | 37,761 | 42,997 | 43,070 | ||||||
| Depreciation (total) | 2,146 | 1,681 | 1,580 | 2,053 | - | ||||||
| Operating Result | 3,125 | 14,141 | 8,126 | 10,656 | 7,875 | ||||||
| Interest Income | -303 | -337 | -328 | -234 | -722 | ||||||
| Income Before Taxes | 2,822 | 13,804 | 7,798 | 10,422 | 7,153 | ||||||
| Income Taxes | 139 | 1,813 | 1,558 | 2,006 | 1,602 | ||||||
| Minority Interests Profit | -31 | -36 | -56 | -113 | 30 | ||||||
| Net Income | 2,806 | 12,314 | 6,223 | 8,371 | 5,400 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 7,744 | 7,449 | 10,522 | 10,526 | 10,258 | ||||||
| Cash Flow from Investing Activities | -1,212 | 3,588 | -7,298 | -2,075 | -6,200 | ||||||
| Cash Flow from Financing | -4,193 | -6,485 | -7,056 | -5,821 | -8,052 | ||||||
| Decrease / Increase in Cash | 2,502 | 4,488 | -3,817 | - | - | ||||||
| Employees | 100,409 | 99,412 | 95,442 | 91,573 | - | ||||||
